Orlando, FL -- (SBWIRE) -- 11/22/2013 -- WallStreetAnalyzed.com primarily focuses on NYSE, NASDAQ, and AMEX and occasionally on PINK and OTCBB companies. WallStreetAnalyzed.com providing you the best fundamental coverage of: Hovnanian Enterprises, Inc.(NYSE:HOV), Affymax, Inc. (OTCMKTS:AFFY), Dex Media Inc (NASDAQ:DXM), Gilead Sciences, Inc. (NASDAQ:GILD).
Hovnanian Enterprises, Inc.(NYSE:HOV), increased3.93% and closed at $5.02 on a traded volume of 4.71 million shares, in comparison to 3.93 million shares of average trading volume. So far this year, the stock is down over -28.29%.
The company has a total market capitalization of $698.79 million and its total outstanding shares are 139.20 million.
Will HOV Continue To Move Higher? Find Out Here
Hovnanian Enterprises Inc. designs, constructs, markets, and sells residential homes in the United States.
Affymax, Inc. (OTCMKTS:AFFY), plunged -3.53% and closed at $0.820on a traded volume of 316,578 shares, whereas its average trading volume is 363,683 shares. In the last three months, the stock is down -48.75%. The Intra-day range for the stock is $0.80 and $0.85.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Dex Media Inc (NASDAQ:DXM), jumped up34.35 % and closed at $7.08. So far in three months, the stock is down -22.71%. The 52-week range for the stock is $4.30 and $23.86 and during the previous trading session it marked$7.39 as its highest price. The stock initially exchanged hands with a price of $5.65 and the overall traded volume that day was 2.73 million shares.
Will DXM Continue To Move Higher? Find Out Here
Dex Media, Inc. provides local, social, and mobile marketing solutions to businesses in communities across the United States under the Dex One and SuperMedia brands.
Gilead Sciences, Inc. (NASDAQ:GILD) after opening its shares at the price of $71.22, jumped up0.77% to close the day at $71.63. The stock ended on a traded volume of 9.16 million shares, in comparison to 9.96million shares of average trading volume. The 52-week range for the stock is $35.68 and $73.20 and during the previous trading session the stock scored the highest price of $71.87.
Why Should Investors Buy GILD After The Recent Gain? Just Go Here and Find Out.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia.
We are a group of Wall Street enthusiasts who enjoy applying our decade long knowledge of the markets and forecasting the outlook for those publicly traded companies. Our primary focus centers on the NYSE, NASDAQ, AMEX and occasionally on PINK and OTCBB companies. While penny stocks are very volatile and high risk plays, in combination with the proper portfolio allotment, these are a very vital additions to your portfolio, especially in low yielding markets. Unless you are looking for savings account or certified deposit low yielding gains and are not risk tolerant, then you have come to the right place.
The disclaimer is to be read and fully understood before using our website, utilizing any of our services, following our social networking platforms, or joining our email list.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS OR SOCIAL NETWORKING PLATFORMS.
We are not registered as a securities broker-dealer or an investment advisor either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
Read full disclaimer at: http://www.wallstreetanalyzed.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)